Single-Photon Emission Computed Tomography Market

Single-Photon Emission Computed Tomography Market: Cardiology & Oncology Expected to be the Top Application Types During the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)

  • 2017-12-21
  • REP-GB-5826
  • 174 pages
  • PDF PPT EXCEL
 Single-Photon Emission Computed Tomography Market

An Incisive, In-depth Analysis on the Single Photon Emission Computed Tomography Market

This study offers a comprehensive, 360 degree analysis on the Single Photon Emission Computed Tomography market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Single Photon Emission Computed Tomography market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Insufficient supply of molecular isotopes and lack of trained and skilled specialists and professionals are the biggest obstacles in the growth of the global SPECT market 

Diagnostic imaging devices require molecular isotopes, however the lack of availability and insufficient supply of molecular isotopes is likely to act as a restraint in the growth of the global SPECT market during the forecast period. For example, two chemical elements such as technetium and molybdenum that generally fuel a large number of SPECT procedures in cardiology have been facing numerous disruptions in supply over the past few years. Another reason responsible for hampering the supply of molecular isotopes is that the reactors supplying molecular isotopes got shut down permanently in Canada owing to reasons related to safety concerns. 

Product recalls is another factor that is creating a negative impact on the worldwide market for SPECT. The use of SPECT devices in diagnosis, staging, restaging and follow up on lesions, diseases and organ dysfunctions, diseases such as cancer, cardiovascular disease and brain dysfunction are associated with adverse effects. Owing to product recalls on account of the adverse effects of SPECT devices the global SPECT market is facing challenges in terms of revenue growth. Poor health care systems especially in developing countries and in countries in the Eastern European region are also expected to restrain the growth of the global SPECT market during the period of study. Lack of basic health care services is anticipated to have an adverse impact on the global market. Lack of funds for advanced health care facilities is another factor that is hampering revenue growth of the global SPECT market.

In order to achieve better imaging capabilities and to offer accurate information related to organ functions and dysfunctions, radioisotope tracers are used by diagnostic and imaging devices. The radioisotope tracer Technetium-99m is widely preferred in SPECT imaging. However, radioisotope tracers have a half-life of just about six hours, and this limits the usage of these tracers in the diagnostic imaging industry. This factor has decreased the popularity of SPECT imaging, thereby negatively impacting the global SPECT market.

Top application areas of SPECT, SPECT-CT and SPECT-MRI imaging devices

SPECT is a powerful nuclear medicine technique that allows non-invasive diagnostic imaging of the metabolic process using short lived radioisotopes thus generating 3-D images of functional processes in the human body. There are numerous applications of SPECT scanners in the global market. One of the main uses of SPECT imaging is in the detection of chronic disorders.

Cardiology

SPECT can be used to assess the extent of cardiovascular disease. SPECT helps in identifying patients who are likely to benefit from heart bypass surgery. SPECT imaging is also used for the diagnosis of ischemic heart disease. Cardiology is a relatively mature application area in the global SPECT market.

Oncology

SPECT imaging is useful in the staging and restaging of malignant tumors. It also helps in locating the best site for biopsy of a suspected tumor.

Neurology

SPECT is used to diagnose, plan treatment and predict outcomes in various neurological disease states by monitoring the effects of therapy either with the help of radiation or chemotherapy or both.

Cardiology and Oncology are the top two application segments in the global SPECT market in terms of revenue share. However, the Neurology segment is expected to grow at the fastest rate of 7.9% during the forecast period. Cardiology and Oncology are the most attractive segments by application in the global SPECT market, with a market attractiveness index of 1.4.

“Single-Photon Emission Computed Tomography Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027),” is Future Market Insights’ recent report which offers insights on the various factors driving the popularity of single-photon emission computed tomography (SPECT) in seven regions across the globe. The report includes an extensive analysis of key industry drivers, restraints, market trends and market structure. The market study provides a comprehensive assessment of stakeholder strategies and imperatives for succeeding in the business. The report segregates the market based on product type, application, end user and region. Impact analysis of key growth drivers and restraints, based on the weighted average model is included in this report to facilitate clients with crystal clear decision-making insights. While analysing the data the analysts have not only considered the historical trends but also statistical analysis and government support analysis have been taken into consideration.

Major countries’ GDP analysis has been included in this report. By value and by device development, the global single-photon emission computed tomography market report provides data on global single-photon emission computed tomography along with capacity utilisation and pricing structure across the different regional markets. The report quantifies the market value and market volume share of various segments of the global single-photon emission computed tomography market across the studied regional markets, thereby performing a comprehensive analysis of the global single-photon emission computed tomography market across all levels.

In-depth assessment of capabilities and detailed profiles of key competitors is included in the scope of the report

The report features a competitive landscape to provide clients with a dashboard view, based on categories of providers in the value chain, presence in the single-photon emission computed tomography portfolio and key differentiators. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the single-photon emission computed tomography supply chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on an in-depth assessment of capabilities and success in the marketplace. Detailed profiles of providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the global single-photon emission computed tomography market. 

Market Taxonomy

By Product Type

By Application Type

By End User

By Region

  • Single Imaging     GammaCameras

  • SPECT/CT

 

  • Cardiology

  • Oncology

  • Neurology

  • Others

 

  • Hospitals

  • Diagnostic Imaging Centres

  •  Ambulatory Surgical Centres

 

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific excluding Japan

  • Japan

  • Middle East & Africa

 Report Methodology

Market volume is inferred through in-depth secondary research and validated from industry experts through primary interviews. Each interview is thoroughly analysed and average market volume is deduced and reconfirmed prior to incorporating in the report. The price of single-photon emission computed tomography devices is deduced on the basis of average spending for the development of the particular type of system and associated devices. For forecasting the global single-photon emission computed tomography market, various macroeconomic factors and changing trends have been observed, giving an idea about the future of the market. In the compilation of the report, the forecasts are conducted in terms of CAGR, while other important criteria such as year-on-year growth and incremental dollar opportunity have also been incorporated presenting the client with crystal clear insights and future opportunities likely to emerge in the global single-photon emission computed tomography market. Indicators such as R&D expenditure, research funding from government and non-profit organisations etc. have been considered to arrive at the indicated market numbers. Economic fluctuations have been considered while forecasting market numbers. The top-down approach has been used to assess market numbers for each product category while the bottom-up approach has been used to counter-validate the market estimations.

Single-Photon Emission Computed Tomography Market Reports - Table of Contents

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology